Photos
Reviews
160 Reviews
Tell people what you think
Nicolas Szabofresnais
· September 15, 2015
At the Kay Lab (University of Utah), we work with the Ion Proton. The new Hi-Q templating/sequencing kit gave us 88% of chip loading and more than 120 millions of sequence reads.
Time to analyze the data!
Merci Proton!
Videos
"S is For" | Ion S5 and S5 XL Next Generation Sequencers
109
15
Next Generation Sequencing for Gene Expression Analysis - Seq ...
19
The Workflow | Ion S5 Next Generation Sequencing System
8
Posts

NeoGenomics to join LabCorp and CGI in offering the Oncomine Dx Target Test, the first FDA approved NSCLC CDx test for multiple biomarkers. Read more here: http://pnw-b.ctx.ly/r/5vy4p

Image may contain: text

Another large reference laboratory is offering the Oncomine Dx Target Test, joining our Next-Generation Sequencing Companion Dx Center of Excellence Program to partner in developing NGS-based tests in oncology

NeoGenomics is one of the first laboratories to offer the newly FDA-approved Oncomine Dx Target Test for Non-Small Cell Lung Cancer (NSCLC). This methodology allows rapid analysis of samples compared to previously approved testing approaches.
marketwired.com
Posts